Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

Conditions:   Parathyroid Carcinoma;   Primary Hyperparathyroidism Intervention:   Drug: KHK7580 Sponsor:   Kyowa Hakko Kirin Co., Ltd Recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials